PY0200477A - Antagonistas de receptores de histamina - Google Patents

Antagonistas de receptores de histamina

Info

Publication number
PY0200477A
PY0200477A PY200200200477A PY0200477A PY0200477A PY 0200477 A PY0200477 A PY 0200477A PY 200200200477 A PY200200200477 A PY 200200200477A PY 0200477 A PY0200477 A PY 0200477A PY 0200477 A PY0200477 A PY 0200477A
Authority
PY
Paraguay
Prior art keywords
receptor antagonists
histamine
histamine receptor
receptor
antagonist
Prior art date
Application number
PY200200200477A
Other languages
English (en)
Spanish (es)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael A Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PY0200477A publication Critical patent/PY0200477A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PY200200200477A 2001-01-17 2002-01-14 Antagonistas de receptores de histamina PY0200477A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
PY0200477A true PY0200477A (es) 2004-06-01

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
PY200200200477A PY0200477A (es) 2001-01-17 2002-01-14 Antagonistas de receptores de histamina

Country Status (32)

Country Link
EP (1) EP1353657A1 (pl)
JP (1) JP2004517883A (pl)
KR (1) KR20030069216A (pl)
CN (1) CN1486178A (pl)
AP (1) AP2002002401A0 (pl)
AR (1) AR032101A1 (pl)
BG (1) BG107834A (pl)
BR (1) BR0206502A (pl)
CA (1) CA2435121A1 (pl)
CR (1) CR6983A (pl)
CZ (1) CZ20031853A3 (pl)
DO (1) DOP2002000325A (pl)
EA (1) EA200300537A1 (pl)
EC (1) ECSP034692A (pl)
EE (1) EE200300335A (pl)
GB (1) GB0101223D0 (pl)
GT (1) GT200200003A (pl)
HU (1) HUP0302767A2 (pl)
IL (1) IL156087A0 (pl)
IS (1) IS6818A (pl)
MA (1) MA26980A1 (pl)
MX (1) MXPA03006408A (pl)
NO (1) NO20033223L (pl)
OA (1) OA12440A (pl)
PA (1) PA8537101A1 (pl)
PL (1) PL362793A1 (pl)
PY (1) PY0200477A (pl)
SK (1) SK8572003A3 (pl)
SV (1) SV2003000849A (pl)
TN (1) TNSN02003A1 (pl)
WO (1) WO2002056871A2 (pl)
ZA (1) ZA200304180B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3378476A1 (en) 2012-06-08 2018-09-26 Sensorion H4 receptor inhibitors for treating tinnitus
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
DOP2002000325A (es) 2003-01-31
NO20033223D0 (no) 2003-07-16
EE200300335A (et) 2003-12-15
MA26980A1 (fr) 2004-12-20
PL362793A1 (pl) 2004-11-02
IL156087A0 (en) 2003-12-23
GT200200003A (es) 2002-08-19
CZ20031853A3 (cs) 2004-07-14
JP2004517883A (ja) 2004-06-17
AR032101A1 (es) 2003-10-22
BR0206502A (pt) 2003-10-21
HUP0302767A2 (hu) 2003-11-28
CR6983A (es) 2003-11-25
TNSN02003A1 (fr) 2005-12-23
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
SK8572003A3 (en) 2004-07-07
MXPA03006408A (es) 2003-10-15
SV2003000849A (es) 2003-01-13
KR20030069216A (ko) 2003-08-25
EA200300537A1 (ru) 2004-02-26
GB0101223D0 (en) 2001-02-28
ZA200304180B (en) 2004-06-15
EP1353657A1 (en) 2003-10-22
IS6818A (is) 2003-05-15
CA2435121A1 (en) 2002-07-25
ECSP034692A (es) 2003-08-29
BG107834A (bg) 2004-01-30
WO2002056871A2 (en) 2002-07-25
PA8537101A1 (es) 2002-08-29
NO20033223L (no) 2003-07-16
OA12440A (en) 2006-05-22

Similar Documents

Publication Publication Date Title
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
PT1300398E (pt) Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
NO20033424L (no) 3,4-disubstituerte syklobuten-1,2-dioner som CXC- kjemokinreseptorantagonister
HN2001000027A (es) Derivados de purina
HN2003000417A (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
PT1328269E (pt) Associacao de um antagonista do receptor cb1 e de sibutramina composicoes farmaceuticas que os contem e sua utilizacao para o tratamento da obesidade
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
AR028505A1 (es) Utilizacion de un antagonista de los receptores de cannabinoides centrales para la preparacion de medicamentos utiles para que sea mas frcil detener el consumo de tabaco
NO993350L (no) Vitronectin-reseptor-antagonister
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
CY1108649T1 (el) Υποκατεστημενα αρυλπυραζολια ως παρασιτοκτονα
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
PY0200477A (es) Antagonistas de receptores de histamina
SV2003001179A (es) Formulacion de 2-metilo-tieno-benzodiacepina liofilizada ref. x-11102
CY1107415T1 (el) Φαρμακευτικη συνθεση η οποια συνδυαζει τενατοπροζολη και εναν ανταγωνιστη των υποδοχεων h2 της ισταμινης
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
UY27124A1 (es) Antagonistas de receptores de histamina